You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rectal cancer BRAF

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • BRAF V600E Mutation Positive
  • Encorafenib Oral Capsule + Cetuximab
  • (no location specified)
Jan 30, 2023

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Terminated
  • Metastatic Colon Adenocarcinoma
  • +27 more
  • San Francisco, California
  • +1 more
Jan 5, 2023

Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,

Completed
  • Colorectal Cancer
  • +12 more
  • Anlotinib Hydrochloride
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 12, 2022

Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer Trial in United States (trametinib, fluorouracil,

Active, not recruiting
  • Recurrent Rectal Cancer
  • +6 more
  • Saint Louis, Missouri
  • +3 more
Feb 15, 2022

Colo-rectal Cancer Trial in Beijing (Experimental: mXELOX plus cetuximab, Active Comparator: FOLFOX plus cetuximab)

Recruiting
  • Colo-rectal Cancer
  • Experimental: mXELOX plus cetuximab
  • Active Comparator: FOLFOX plus cetuximab
  • Beijing, China
    Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Sep 29, 2021

Colo-rectal Cancer, Capecitabine, Cetuximab Trial in Chengdu (mCapOX plus cetuximab, mFOLFOX6 plus cetuximab)

Recruiting
  • Colo-rectal Cancer
  • +2 more
  • mCapOX plus cetuximab
  • mFOLFOX6 plus cetuximab
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Sep 1, 2021

Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • CapeOX + cetuximab
  • +2 more
  • (no location specified)
Sep 12, 2023

Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8 Trial in United States

Recruiting
  • Metastatic Colon Adenocarcinoma
  • +7 more
  • Cetuximab
  • +2 more
  • Bloomington, Illinois
  • +70 more
Aug 6, 2022

Anaplastic Thyroid Cancer Trial in Leiden (dabrafenib/trametinib)

Recruiting
  • Anaplastic Thyroid Cancer
  • Leiden, Zuid-Holland, Netherlands
    Ellen Kapiteijn
Oct 5, 2023

Advanced Colorectal Cancer Trial in Hangzhou (Cetuximab Dabrafenib Tislelizumab)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Cetuximab Dabrafenib Tislelizumab
  • Hangzhou, Zhejing, China
    Zhejiang Cancer Institute & Hospital
Jul 19, 2023

Cancer Trial (Dabrafenib, Trametinib)

Not yet recruiting
  • Cancer
  • (no location specified)
May 25, 2023

Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago

Recruiting
  • Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
  • +2 more
  • Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
  • Chicago, Illinois
    Northwestern University
Nov 16, 2022

Aspirin in Combination With Trametinib and Dabrafenib

Not yet recruiting
  • NSCLC
  • +4 more
  • Combind asprin with Trametinib and Dabrafenib
  • (no location specified)
Aug 4, 2023

MRI T1 Relaxation Time in Rectal Cancer

Recruiting
  • Rectal Cancer
  • Locally Advanced Rectal Carcinoma
    • Vejle, Jylland, Denmark
      Vejle Hospital
    May 16, 2023

    BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,

    Recruiting
    • BRAF NP_004324.2:p.V600E
    • +2 more
    • Duarte, California
    • +1 more
    Jan 19, 2023

    Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

    Not yet recruiting
    • Colorectal Cancer
    • +4 more
    • (no location specified)
    Aug 18, 2022

    Advanced Rectal Cancer, Distal Metastasis Trial in Shanghai (a combination therapy)

    Not yet recruiting
    • Advanced Rectal Cancer
    • Distal Metastasis
    • a combination therapy including tislelizumab
    • Shanghai, Shanghai, China
      Xinxiang Li
    Nov 12, 2022

    NSCLC, BRAF V600 Mutation, MET Exon 14 Mutation Trial in Guangzhou (Dabrafenib + Trametinib, Capmatinib)

    Not yet recruiting
    • NSCLC
    • +2 more
    • Guangzhou, Guangdong, China
      Cancer Center of Sun-Yat Sen University
    Sep 19, 2023

    Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,

    Not yet recruiting
    • Colon Adenocarcinoma
    • +4 more
    • (no location specified)
    Jan 24, 2023

    Cancer Harboring BRAF Alterations Trial (FORE8394, Cobicistat)

    Not yet recruiting
    • Cancer Harboring BRAF Alterations
    • (no location specified)
    Aug 15, 2022

    TakingLook at Patient Experiences In Rectal Cancer Clinical

    Not yet recruiting
    • Rectal Cancer
      • San Francisco, California
        Power Life Sciences
      Jun 9, 2023

      Locally Advanced Rectal Cancer, Locally Recurrent Rectal Cancer Trial in Southampton (Intraoperative Electron Radiotherapy

      Recruiting
      • Locally Advanced Rectal Cancer
      • Locally Recurrent Rectal Cancer
      • Intraoperative Electron Radiotherapy (IOERT)
      • Extended Margin Surgery
      • Southampton, Hampshire, United Kingdom
        University Hospital Southampton NHS Foundation Trust
      May 24, 2023